Aekta Singareddy
About Aekta Singareddy
Aekta Singareddy is the Manager of Oncology Medical Communications at Bristol-Myers Squibb in Lawrence, New Jersey, with a background in virology and oncology medical communications.
Current Role at Bristol-Myers Squibb
Aekta Singareddy currently holds the position of Manager, Oncology Medical Communications at Bristol-Myers Squibb. She is based in Lawrence, New Jersey. In this role, she is responsible for managing communications related to oncology, contributing to the dissemination of crucial medical information within the organization and to external stakeholders.
Previous Experience at Bristol-Myers Squibb
Prior to her current position, Aekta Singareddy worked in various roles at Bristol-Myers Squibb. From 2014 to 2016, she was the Manager of Virology Medical Information, and from 2013 to 2014, she served as a Consultant in the same department. Both positions were located in Plainsboro, NJ, where she focused on the dissemination of medical information related to virology.
Early Career at Sentrx (Telerx)
Aekta Singareddy began her career at Sentrx, a part of Telerx, where she worked as a Medical Communications Specialist in 2013 for two months. Before that, she served as a Medical Communications Associate from 2012 to 2013 for ten months. Both roles were based in Little Falls, NJ, and involved responsibilities related to medical communications in the healthcare sector.
Educational Background in Pharmacy
Aekta Singareddy studied at the University of the Sciences in Philadelphia, where she completed a Doctor of Pharmacy (PharmD) program. She attended the institution from 2006 to 2012, gaining a comprehensive education in pharmacy, which laid the foundation for her subsequent roles in medical communications and information.
Expertise in Virology and Oncology Communications
Aekta Singareddy has accumulated significant experience in both virology and oncology medical communications. Her diverse expertise is demonstrated by her roles at Bristol-Myers Squibb, where she transitioned from Virology Medical Information to Oncology Medical Communications in 2017. This background showcases her ability to handle complex medical information across different therapeutic areas.